Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Amit K. Mitra"'
Autor:
Taraswi Mitra Ghosh, Jason White, Joshua Davis, Suman Mazumder, Teeratas Kansom, Elena Skarupa, Grafton S. Barnett, Gary A. Piazza, R. Curtis Bird, Amit K. Mitra, Clayton Yates, Brian S. Cummings, Robert D. Arnold
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Repetitive, low-dose (metronomic; METRO) drug administration of some anticancer agents can overcome drug resistance and increase drug efficacy in many cancers, but the mechanisms are not understood fully. Previously, we showed that METRO dosing of to
Externí odkaz:
https://doaj.org/article/78bf5631e26f44058e9dd33c413cb9f1
Autor:
Jatinder K. Lamba, Soheil Meshinchi, Alan Gamis, Raul C. Ribeiro, Jeffrey E. Rubnitz, Xueyuan Cao, Stanley Pounds, Janet Franklin, Susana Raimondi, Betsy Hirsch, Michael R. Loken, Jessica A. Pollard, Amit K. Mitra, Robert B. Gerbing, Roland B. Walter, Todd A. Alonzo, Leslie Mortland
Supplementary Table 2. Characteristics of pediatric AML patients treated on St. Jude AML02 trial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eb316bad638afbd2f6678728480de35
https://doi.org/10.1158/1078-0432.22452522.v1
https://doi.org/10.1158/1078-0432.22452522.v1
Autor:
Jatinder K. Lamba, Soheil Meshinchi, Alan Gamis, Raul C. Ribeiro, Jeffrey E. Rubnitz, Xueyuan Cao, Stanley Pounds, Janet Franklin, Susana Raimondi, Betsy Hirsch, Michael R. Loken, Jessica A. Pollard, Amit K. Mitra, Robert B. Gerbing, Roland B. Walter, Todd A. Alonzo, Leslie Mortland
Supplementary Table 1. Characteristics of pediatric AML patients treated on AAML03P1 trial by four CD33 SNPs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc4b90ee960f223e00969281f6eca97a
https://doi.org/10.1158/1078-0432.22452525
https://doi.org/10.1158/1078-0432.22452525
Autor:
Jatinder K. Lamba, Soheil Meshinchi, Alan Gamis, Raul C. Ribeiro, Jeffrey E. Rubnitz, Xueyuan Cao, Stanley Pounds, Janet Franklin, Susana Raimondi, Betsy Hirsch, Michael R. Loken, Jessica A. Pollard, Amit K. Mitra, Robert B. Gerbing, Roland B. Walter, Todd A. Alonzo, Leslie Mortland
Purpose: The purpose of this study was to evaluate clinical implications of CD33 single-nucleotide polymorphisms (SNP) in pediatric patients with acute myeloid leukemia (AML) treated with gemtuzumab-ozogamicin (GO)–based therapy.Experimental Design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3acb29442155e1f2616f7003b8126451
https://doi.org/10.1158/1078-0432.c.6522501.v1
https://doi.org/10.1158/1078-0432.c.6522501.v1
Autor:
Abdelrahman H. Elsayed, Xueyuan Cao, Amit K. Mitra, Huiyun Wu, Susana Raimondi, Christopher Cogle, Zeina Al-Mansour, Raul C. Ribeiro, Alan Gamis, Edward Anders Kolb, Richard Aplenc, Todd A. Alonzo, Soheil Meshinchi, Jeffrey Rubnitz, Stanley Pounds, Jatinder K. Lamba
Publikováno v:
J Clin Oncol
PURPOSE To establish a patient-specific polygenic score derived from cytarabine (ara-C) pathway pharmacogenomic evaluation to personalize acute myeloid leukemia (AML) treatment. MATERIALS AND METHODS Single nucleotide polymorphisms (SNPs) in the ara-
Autor:
Suman Mazumder, Taraswi Mitra Ghosh, Ujjal K. Mukherjee, Sayak Chakravarti, Farshad Amiri, Razan S. Waliagha, Farnaz Hemmati, Panagiotis Mistriotis, Salsabil Ahmed, Isra Elhussin, Ahmad-Bin Salam, Windy Dean-Colomb, Clayton Yates, Robert D. Arnold, Amit K. Mitra
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 6009
Metastatic prostate cancer/PCa is the second leading cause of cancer deaths in US men. Most early-stage PCa are dependent on overexpression of the androgen receptor (AR) and, therefore, androgen deprivation therapies/ADT-sensitive. However, eventual
Autor:
Suman Mazumder, Taraswi Mitra Ghosh, Ujjal K. Mukherjee, Sayak Chakravarti, Farshad Amiri, Farnaz Hemmati, Panagiotis Mistriotis, Isra Elhussin, Ahmad-bin Salam, Windy Dean-Colomb, Feng Li, Clayton Yates, Robert D. Arnold, Amit K. Mitra
Metastatic prostate cancer is the second leading cause of cancer deaths in US men. Resistance to standard medical castration and secondary taxane-based chemotherapy is nearly universal. Further, presence of cancer stem-like cells (EMT/epithelial to m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2423b51818457caa5236e5cca42aa714
https://doi.org/10.1101/2022.07.20.500378
https://doi.org/10.1101/2022.07.20.500378
Autor:
Taraswi Mitra Ghosh, Adam B. Keeton, Xi Chen, Salsabil Ahmed, Razan S. Waliagha, Gary A. Piazza, Amit K. Mitra
Publikováno v:
Cancer Research. 83:1638-1638
Metastatic prostate cancer is the second leading cause of cancer deaths in US men. Most early-stage PCa are dependent on overexpression of the androgen receptor (AR) and are therefore sensitive to androgen deprivation therapies. However, eventual res
Autor:
Taraswi Mitra Ghosh, Teeratas Kansom, Suman Mazumder, Joshua Davis, Ahmed S. Alnaim, Shanese L. Jasper, Chu Zhang, Aedan Bird, Praneet Opanasopit, Amit K. Mitra, Robert D. Arnold
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 380(3)
Conventional treatment with taxanes (docetaxel-DTX or cabazitaxel-CBZ) increases the survival rates of patients with aggressive metastatic castration-resistant prostate cancer (mCRPC); however, most patients acquire resistance to taxanes. The androgr
Autor:
Taraswi Mitra Ghosh, Jason White, Suman Mazumder, Joshua Davis, Grace Hurley, Brian Cummings, Gary Piazza, Amit K Mitra, Clayton Yates, Robert Arnold
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-126
Introduction: The incidence of aggressive prostate cancer (PCa) and mortality is disproportionately higher in men of African-American (AA) ancestry. Treatment options for these patients are docetaxel or cabazitaxel alone or in combination with bevaci